Silihan lan utang jangka dawa perusahaan: Reviva Pharmaceuticals Holdings (RVPH)

The Reviva Pharmaceuticals (RVPH) long-term liabilities chart on the GURU.Markets platform, which currently stands at 0.00, is based on the development of safe treatments for psoriasis and schizophrenia. Warehouse reserves guarantee the stability of component supplies for testing. However, the lack of profitability and uncertainty regarding the outcome of final-stage trials create serious financial threats for the company.

This indicator measures the total volume of long-term liabilities, allowing for an assessment of the capital structure's stability and the risk of credit pressure on the business. By analyzing the long-term debt history of Reviva Pharmaceuticals (RVPH), an investor can track borrowing trends, which is critical for Reviva Pharmaceuticals (RVPH) as the lack of operating revenue during the neuroleptic development stage makes the company dependent on external financing and the cost of debt service.